X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs J.B.CHEMICALS - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD J.B.CHEMICALS ALEMBIC LTD/
J.B.CHEMICALS
 
P/E (TTM) x 50.6 16.7 303.3% View Chart
P/BV x 2.2 2.3 95.9% View Chart
Dividend Yield % 0.5 0.2 274.4%  

Financials

 ALEMBIC LTD   J.B.CHEMICALS
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
J.B.CHEMICALS
Mar-16
ALEMBIC LTD/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs72318 22.6%   
Low Rs34200 17.0%   
Sales per share (Unadj.) Rs4.7148.0 3.2%  
Earnings per share (Unadj.) Rs6.119.1 32.0%  
Cash flow per share (Unadj.) Rs6.223.9 26.1%  
Dividends per share (Unadj.) Rs0.200.50 40.0%  
Dividend yield (eoy) %0.40.2 195.5%  
Book value per share (Unadj.) Rs40.7128.9 31.5%  
Shares outstanding (eoy) m267.0384.82 314.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.31.7 644.1%   
Avg P/E ratio x8.713.6 64.0%  
P/CF ratio (eoy) x8.510.8 78.4%  
Price / Book Value ratio x1.32.0 64.9%  
Dividend payout %3.32.6 125.1%   
Avg Mkt Cap Rs m14,13921,951 64.4%   
No. of employees `000NA2.7 0.0%   
Total wages/salary Rs m2071,841 11.3%   
Avg. sales/employee Rs ThNM4,590.9-  
Avg. wages/employee Rs ThNM673.4-  
Avg. net profit/employee Rs ThNM592.1-  
INCOME DATA
Net Sales Rs m1,25512,551 10.0%  
Other income Rs m370542 68.4%   
Total revenues Rs m1,62513,093 12.4%   
Gross profit Rs m1112,055 5.4%  
Depreciation Rs m38412 9.2%   
Interest Rs m296 1.8%   
Profit before tax Rs m4422,088 21.2%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24469 5.1%   
Profit after tax Rs m1,6301,619 100.7%  
Gross profit margin %8.916.4 54.1%  
Effective tax rate %5.422.5 24.1%   
Net profit margin %129.812.9 1,006.8%  
BALANCE SHEET DATA
Current assets Rs m1,8677,778 24.0%   
Current liabilities Rs m5914,358 13.6%   
Net working cap to sales %101.627.2 373.1%  
Current ratio x3.21.8 177.0%  
Inventory Days Days9455 172.4%  
Debtors Days Days7480 91.9%  
Net fixed assets Rs m1,7915,713 31.3%   
Share capital Rs m534170 314.9%   
"Free" reserves Rs m10,32410,547 97.9%   
Net worth Rs m10,85810,937 99.3%   
Long term debt Rs m410-   
Total assets Rs m11,59115,574 74.4%  
Interest coverage x260.922.8 1,143.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.10.8 13.4%   
Return on assets %14.111.0 127.9%  
Return on equity %15.014.8 101.4%  
Return on capital %15.220.0 76.1%  
Exports to sales %1.548.7 3.2%   
Imports to sales %21.07.1 296.3%   
Exports (fob) Rs m196,115 0.3%   
Imports (cif) Rs m263889 29.6%   
Fx inflow Rs m196,169 0.3%   
Fx outflow Rs m2641,285 20.5%   
Net fx Rs m-2444,884 -5.0%   
CASH FLOW
From Operations Rs m2361,397 16.9%  
From Investments Rs m-224-320 69.9%  
From Financial Activity Rs m-27-1,196 2.2%  
Net Cashflow Rs m-15-102 14.5%  

Share Holding

Indian Promoters % 64.0 55.4 115.5%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 0.2 3.4 5.9%  
FIIs % 9.7 3.9 248.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 37.0 70.5%  
Shareholders   54,701 30,437 179.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   STRIDES PHARMA SCIENCE  ELDER PHARMA  VENUS REMEDIES  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens 450 Points Down; All Eyes on State Election Results & Urjit Patel's Resignation(09:30 am)

Asian stock markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.1% while the Hang Seng is also up 0.1%.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Dec 11, 2018 11:49 AM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS